BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/30/2016 5:41:00 PM | Browse: 1570 | Download: 2358
Publication Name World Journal of Clinical Oncology
Manuscript ID 21679
Country Lebanon
ISSN 2218-4333 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Medicine, General & Internal
Manuscript Type Review
Article Title Overview, prevention and management of chemotherapy extravasation
Manuscript Source Invited Manuscript
All Author List Firas Y Kreidieh, Hiba A Moukadem and Nagi S El Saghir
Funding Agency and Grant Number
Corresponding Author Nagi S El Saghir, MD, FACP, Professor of Clinical Medicine, Director (Breast Center of Excellence, NK Basile Cancer Institute), Division of Hematology-Oncology, Department of Internal Medicine, American University of Beirut Medical Center, PO Box 11-0236, Riad El Solh 1107 2020, Beirut, Lebanon. nagi.saghir@aub.edu.lb
Key Words Chemotherapy; Extravasation; Vesicant; Tissue damage; Dimethyl sulfoxide; Dexrazoxane; Antidote; Hyaluronidase
Core Tip Chemotherapy administration carries safety concerns, which include accidental extravasation, to patients. We review and update readers and health care providers on the risks of chemotherapy extravasation, prevention and management. We present the definitions, grading, classification and guidelines related to chemotherapeutic drugs and groups. We present an update on prevention and management and antidotes, particularly dexrazoxane for anthracyclines extravasation. We present summary statements of American Society of Clinical Oncology, European Society of medical Oncology, Oncology Nursing Society and European Oncology Nursing Society guidelines. We stress the importance of education and training of the entire oncology team members who share responsibility to ensure the safe administration of chemotherapy and avoid extravasation.
Publish Date 2016-01-30 17:42
Citation Kreidieh FY, Moukadem HA, El Saghir NS. Overview, prevention and management of chemotherapy extravasation. World J Clin Oncol 2016; 7(1): 87-97
URL http://www.wjgnet.com/2218-4333/full/v7/i1/87.htm
DOI http://dx.doi.org/10.5306/wjco.v7.i1.87
Full Article (PDF) WJCO-7-87.pdf
Full Article (Word) WJCO-7-87.doc